Headline
The latest stories from AHA Today.
As part of its efforts to promote behavioral health strategies, the AHA today released a TrendWatch report outlining the opportunities, barriers and solutions to increase access to behavioral health care.
The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac resynchronization therapy pacemakers may drain more quickly than expected without warning.
The AHA and other plaintiffs late Friday asked a federal district judge to set a firm June deadline for the Department of Health and Human Services to propose remedies to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program.
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a brand name biological product.
Whistleblowers who file a lawsuit within three years of reporting an alleged fraud to a responsible government official may have up to 10 years after the alleged fraud occurred to file a lawsuit.
The House of Representatives yesterday voted 230-183 to pass AHA-supported legislation (H.R. 986) that would rescind the administration’s latest guidance for states seeking a Section 1332 waiver of certain Affordable Care Act requirements.
The Food and Drug Administration yesterday published draft guidance to promote clinical studies to increase drug safety information for pregnant and nursing women and their providers.
The White House yesterday released a strategy to guide the federal government in protecting the nation from infectious disease threats by working with other nations and stakeholders.
President Trump today released guiding principles for addressing surprise medical bills.
The House Energy and Commerce Subcommittee on Health today held a hearing on lowering prescription drugs prices, which focused on the drug supply chain.